<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-826
Date of Submission: 2025-02-23

This report was submitted by a Other Healthcare Professional from Hernandez-Carpenter Medical Center concerning patient ANON-PX-3460. The subject is a 24-year-old female with a significant medical history including chronic kidney disease, atrial fibrillation, osteoarthritis. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Sertraline (SSRI) administered via the Oral route at a dosage of 421mg, initiated on 2024-12-26 for Major depressive disorder and discontinued on 2025-02-18.

On approximately 2025-02-02, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Somnolence, Vomiting. The Somnolence was classified as Severe in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Fatal'. The Vomiting was classified as Mild in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Unknown'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Rechallenge not performed'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Surface theory remain star call. What day last bank.</data>
report_id: ADR-2025-826
report_date: '2025-02-23'
patient_details:
  patient_id: ANON-PX-3460
  gender: Female
  relevant_history:
  - chronic kidney disease
  - atrial fibrillation
  - osteoarthritis
  age_at_reaction: 24
suspected_drugs:
- drug_name: Sertraline
  dosage: 421mg
  route_of_administration: Oral
  start_date: '2024-12-26'
  indication_for_use: Major depressive disorder
  drug_class: SSRI
  end_date: '2025-02-18'
adverse_reactions:
- symptom_name: Somnolence
  onset_date: '2025-02-02'
  severity: Severe
  outcome: Fatal
  intervention_required: false
- symptom_name: Vomiting
  onset_date: '2025-02-02'
  severity: Mild
  outcome: Unknown
  intervention_required: false
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Rechallenge not performed
reporting_facility: Hernandez-Carpenter Medical Center
reporter_type: Other Healthcare Professional
notes: Surface theory remain star call. What day last bank.
